On the same day that Statistics Canada revealed a higher unemployment rate of 6.7% and a youth unemployment rate of 14.1%, the Carney government made it easier for some employers to hire temporary ...
Carnival Cruise Line has rolled out a new, quicker dining experience on 15 of its ships, including three that set sail from Long Beach. Dubbed “Express Dining,” the onboard pilot program offers a ...
The martial art skill of Brazilian Jiu Jitsu is now being used as a tool for local law enforcement officers. Spanish police find body amid search for missing US student New poll shows top 2028 ...
The City of Binghamton has taken the first steps towards potentially bringing a new passenger rail line to the city, thanks to a federal program that offers up to half a million dollars. Binghamton ...
Victor Nechita, who served as Tesla’s vehicle program manager for the Cybercab, has announced he is leaving the company. The departure comes just days after the first Cybercab production unit rolled ...
Alabama parted ways with offensive line coach Chris Kapilovic on Jan. 23, after two seasons with the Crimson Tide. But on Friday, his next chapter was announced as Auburn announced that Kapilovic will ...
Seabourn Cruise Line will end its submarine program in March, in part due to limited guest interest. Passenger participation rates have been lower than the cruise line had anticipated, it said.
What does your role as a student producer entail? My role as a student producer made me responsible for running sprint planning and review meetings, assigning weekly tasks for all team members, and ...
Iranian Foreign Minister Abbas Araghchi said his country would not negotiate on its ballistic missile program, rejecting a core U.S. demand and further dimming prospects for a breakthrough deal. He ...
Residents in Denver's Globeville, Elyria, and Swansea neighborhoods raised concerns about changes to a community grant program that now limits eligibility to organizations and groups, saying the shift ...
(RTTNews) - Galectin Therapeutics Inc. (GALT) Friday announced that the U.S. FDA has provided written feedback on its development program for Belapectin, the company's investigational galectin-3 ...